57 -10 (48) 2022 — Toshov S.S., Kamilova U.K. — STUDY OF CARDIOVACULAR COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

STUDY OF CARDIOVACULAR COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Toshov S.S., Bukhara State Medical Institute, “Republican Scientific and Practical Center of Specialized Therapy and Medical Rehabilitation” SC, Tashkent, Uzbekistan

Kamilova U.K. Bukhara State Medical Institute, “Republican Scientific and Practical Center of Specialized Therapy and Medical Rehabilitation” SC, Tashkent, Uzbekistan

Resume

The article presents data on the prevalence of cardiovascular risk factors and the occurrence of diseases of the cardiovascular wall in patients with chronic obstructive pulmonary disease.

Key words: chronic obstructive pulmonary disease, cardiovascular system, risk factors

First page

310

Last page

314

For citation:Toshov S.S., Kamilova U.K. – STUDY OF CARDIOVACULAR COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE //New Day in Medicine 10(48)2022 310-314 https://clck.ru/32XowP

LIST OF REFERENCES:

1. Айсанов З.Р., Чучалин А.Г., Калманова Е.Н. Хроническая обструктивная болезнь легких и сердечно-сосудистая коморбидность. // Кардиология. 2019;59(8S):24-36. https://doi.org/10.18087/cardio.2572
2. Клинические рекомендации. Хроническая обструктивная болезнь легких. // Межрегиональная общественная организация «Российское Респираторное Общество». 2021. 91 с.
3. Пунин Д.А., Милягин В.А. Особенности состояния сердечно-сосудистой системы у пациентов с хронической обструктивной болезнью легких по результатам контурного анализа пульсовой волны. // Архивъ внутренней медицины. 2020;10(1):61-67.
4. Чучалин А.Г., Авдеев С.Н., Айсанов З.Р., Белевский А.С., Лещенко И.В., Овчаренко С.И., Шмелев Е.И. Хроническая обструктивная болезнь легких: федеральные клинические рекомендации по диагностике и лечению. // Пульмонология. 2022;32(3):356-392.
5. 2021 Report Global strategy for prevention, diagnosis and management of COPD (Global Initiative for Obstructive Lung Disease, GOLD 2021)
6. Ahn Y.H., Lee K.S., Park J.H. et al. Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations. // Respiration. 2015; 90(3):199-205.
7. Morgan A.D., Zakeri R., Quint J.K. Defining the relationship between COPD and CVD: what are the implications for clinical practice? // Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465817750524. doi: 10.1177/1753465817750524.
8. Patel AR.C., Donaldson G.C., Mackay A.J., Wedzicha J.A., Hurst J.R. The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD. // Chest. 2012 Apr;141(4):851-857. doi: 10.1378/chest.11-0853. Epub 2011 Sep 22. PMID: 21940771.
9. Roversi S., Fabbri L.M. Interazioni cuore-polmoni: la broncopneumopatia cronica ostruttiva e la cardiopatia ischemica [Lung and heart interaction: chronic obstructive pulmonary disease and ischemic heart disease]. // G Ital Cardiol (Rome). 2018 Mar;19(3):153-160. Italian. doi: 10.1714/2883.29073. PMID: 29873642.
10. Xiong M.Q., Hu W.H., Hu K. et al. Analysis of risk factors and consequences for concurrent obstructive sleep apnea in chronic obstructive pulmonary disease patients].
11. World Health Organization. 2022.https://www.who.int/ru/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)